JP2023523155A5 - - Google Patents
Info
- Publication number
- JP2023523155A5 JP2023523155A5 JP2022560857A JP2022560857A JP2023523155A5 JP 2023523155 A5 JP2023523155 A5 JP 2023523155A5 JP 2022560857 A JP2022560857 A JP 2022560857A JP 2022560857 A JP2022560857 A JP 2022560857A JP 2023523155 A5 JP2023523155 A5 JP 2023523155A5
- Authority
- JP
- Japan
- Prior art keywords
- once
- days
- pharmaceutical composition
- group
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063012428P | 2020-04-20 | 2020-04-20 | |
| US63/012,428 | 2020-04-20 | ||
| PCT/IB2021/000261 WO2021214545A1 (en) | 2020-04-20 | 2021-04-20 | Transdermal and/or topical pharmaceutical formulations comprising cannabidiol and/or tetrahydrocannabinol for the treatment of chronic pain |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023523155A JP2023523155A (ja) | 2023-06-02 |
| JP2023523155A5 true JP2023523155A5 (enExample) | 2024-05-23 |
Family
ID=78270322
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022560857A Pending JP2023523155A (ja) | 2020-04-20 | 2021-04-20 | 慢性疼痛治療のためのカンナビジオール及び／又はテトラヒドロカンナビノールを含有する経皮製剤及び／又は局所製剤 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US20210346310A1 (enExample) |
| EP (1) | EP4110325A4 (enExample) |
| JP (1) | JP2023523155A (enExample) |
| CN (1) | CN115916184A (enExample) |
| AU (1) | AU2021259495A1 (enExample) |
| CA (1) | CA3178878A1 (enExample) |
| MX (1) | MX2022012415A (enExample) |
| WO (1) | WO2021214545A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12186280B2 (en) | 2019-10-11 | 2025-01-07 | Pike Therapeutics Inc. | Pharmaceutical composition and method for treating seizure disorders |
| US12268699B2 (en) | 2019-10-14 | 2025-04-08 | Pike Therapeutics Inc. | Transdermal delivery of tetrahydrocannabinol |
| JP2022551730A (ja) | 2019-10-14 | 2022-12-13 | パイク セラピューティクス，インコーポレイテッド | カンナビジオールの経皮送達 |
| US12121617B2 (en) | 2019-10-14 | 2024-10-22 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| WO2022003623A1 (en) * | 2020-07-01 | 2022-01-06 | Pike Therapeutics, Inc. | Transdermal pharmaceutical formulations for the treatment of multiple sclerosis |
| MX2023006561A (es) * | 2020-12-03 | 2023-07-06 | Pike Therapeutics Inc | Formulaciones farmaceuticas transdermicas que comprenden cbd o thc para el tratamiento del cancer. |
| AU2022257344A1 (en) * | 2021-04-12 | 2023-10-26 | Pike Therapeutics Inc. | Transdermal delivery of cannabidiol |
| AU2022260813A1 (en) * | 2021-04-22 | 2023-10-26 | Pike Therapeutics Inc. | Transdermal pharmaceutical formulations for the treatment of chronic pain |
| EP4366728A4 (en) * | 2021-07-08 | 2025-05-14 | Innocan Pharma Ltd. | COMPOSITIONS FOR THE TREATMENT OF DIABETIC SYMPTOMS |
| US20230059204A1 (en) * | 2021-08-03 | 2023-02-23 | Pike Therapeutics, Inc. | Transdermal micro-dosing delivery of pharmaceutical agents |
| US20250222012A1 (en) * | 2021-11-02 | 2025-07-10 | Schedule 1 Therapeutics, Inc. | Use of cannabinoid compositions for treating pain associated with small fiber neuropathy |
| US20240024253A1 (en) * | 2022-07-21 | 2024-01-25 | Pike Therapeutics Inc. | Continuous Drug Delivery Systems and Methods |
| US11826342B1 (en) * | 2022-09-27 | 2023-11-28 | Saaransh Mahna | Cannabidiol formulation for alleviating pain and a method of manufacturing |
| CN118045221B (zh) * | 2024-02-04 | 2024-07-19 | 广东云曌医疗科技有限公司 | 一种水凝胶敷料及其制备方法和应用 |
| WO2026018119A1 (en) * | 2024-07-16 | 2026-01-22 | Pike Therapeutics Inc. | Transdermal delivery of tetrahydrocannabinol |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2414933B (en) * | 2004-06-08 | 2009-07-15 | Gw Pharma Ltd | Cannabinoid compositions for the treatment of disease and/or symptoms in arthritis |
| US20080112895A1 (en) * | 2006-08-04 | 2008-05-15 | Insys Therapeutics Inc. | Aqueous dronabinol formulations |
| DK2176208T3 (en) * | 2007-07-30 | 2015-04-27 | Zynerba Pharmaceuticals Inc | Prodrugs of cannabidiol, compositions containing prodrugs of cannabidiol and methods of use thereof |
| WO2010127033A1 (en) * | 2009-04-28 | 2010-11-04 | Alltranz Inc. | Formulations of cannabidiol and methods of using the same |
| EP2424568A1 (en) * | 2009-04-29 | 2012-03-07 | University Of Kentucky Research Foundation | Cannabinoid-containing compositions and methods for their use |
| PT2473475T (pt) * | 2009-08-31 | 2017-08-02 | Zynerba Pharmaceuticals Inc | Utilização de profármacos de canabidiol na administração tópica e transdérmica com microagulhas |
| AT509000B1 (de) * | 2009-10-23 | 2012-12-15 | Rausch Peter | Wasserlösliche zubereitungen von cannabinoiden und cannabispräparaten und deren anwendungen |
| US9408802B1 (en) * | 2012-03-22 | 2016-08-09 | Prosolus, Inc. | Seven day drug in adhesive transdermal delivery |
| US9095563B2 (en) * | 2013-09-26 | 2015-08-04 | Ronald D. Sekura | Topical treatments incorporating Cannabis sp. derived botanical drug product |
| US20160022627A2 (en) * | 2014-04-18 | 2016-01-28 | Mary's Medicinals LLC | Transdermal cannabinoid patch |
| US9375417B2 (en) * | 2014-12-04 | 2016-06-28 | Mary's Medicinals LLC | Transdermal cannabinoid formulations |
| CA2976004C (en) * | 2015-02-05 | 2020-06-02 | Colorado Can Llc | Purified cbd and cbda, and methods, compositions and products employing cbd or cbda |
| BR112017018944A2 (en) * | 2015-03-02 | 2018-05-15 | Afgin Pharma, Llc | method of treating a disease state or condition in humans with a carbinoid drug, and method of treating a disease state or condition in a mammal other than a human with carbinoid drug (s) |
| WO2016144376A1 (en) * | 2015-03-10 | 2016-09-15 | Nanosphere Health Sciences, Llc | Lipid nanoparticle compositions and methods as carriers of cannabinoids in standardized precision-metered dosage forms |
| US10272125B2 (en) * | 2015-09-14 | 2019-04-30 | Life Tech Global, Llc | Transdermal delivery of cannabidiol with other active moieties including cannabinoids |
| MX2018004034A (es) * | 2015-09-30 | 2018-12-19 | Edward Hoag George | Formulaciones topicas de analgesicos para alivio del dolor fabricacion y uso de los mismos. |
| JP2019537628A (ja) * | 2016-11-02 | 2019-12-26 | ティクン オラム リミテッドＴｉｋｕｎ Ｏｌａｍ ＬＴＤ | 併用療法 |
| US10702495B2 (en) * | 2017-02-20 | 2020-07-07 | Nexien Biopharma, Inc. | Method and compositions for treating dystrophies and myotonia |
| FR3064334B1 (fr) * | 2017-03-24 | 2021-05-14 | Dcns Energies | Presse-etoupe de traversee etanche d'un orifice d'une cloison |
| US12357604B2 (en) * | 2017-09-22 | 2025-07-15 | Inmed Pharmaceuticals Inc. | Topical formulations of cannabinoids and use thereof in the treatment of pain |
| CA3076929A1 (en) * | 2017-09-25 | 2019-03-28 | Canopy Health Innovations | Compositions comprising cannabidiol, tetrahydrocannabinol, terpenes, and flavonoids and use thereof in the treatment of insomnia |
| IL292126B2 (en) * | 2018-01-12 | 2025-04-01 | Nutrae Llc | Cannabinoid formulations are formulated for oral administration |
| US20200138772A1 (en) * | 2018-07-09 | 2020-05-07 | Volker Berl | Stabilized formulations of cannabinoid compositions |
| US20210015740A1 (en) * | 2019-03-04 | 2021-01-21 | Michael Harvey Greenspan | Topical cannabinoid compositions, delivery systems, and uses for pain relief |
| EP3969054A4 (en) * | 2019-05-16 | 2023-09-06 | Aegis Therapeutics, LLC | COMPOSITIONS CONTAINING OIL-SOLUBLE DRUGS AND METHODS OF USING SUCH COMPOSITIONS |
-
2021
- 2021-04-20 US US17/235,314 patent/US20210346310A1/en not_active Abandoned
- 2021-04-20 MX MX2022012415A patent/MX2022012415A/es unknown
- 2021-04-20 EP EP21791920.8A patent/EP4110325A4/en not_active Withdrawn
- 2021-04-20 JP JP2022560857A patent/JP2023523155A/ja active Pending
- 2021-04-20 WO PCT/IB2021/000261 patent/WO2021214545A1/en not_active Ceased
- 2021-04-20 CA CA3178878A patent/CA3178878A1/en active Pending
- 2021-04-20 AU AU2021259495A patent/AU2021259495A1/en active Pending
- 2021-04-20 CN CN202180042209.2A patent/CN115916184A/zh active Pending
-
2025
- 2025-03-24 US US19/087,734 patent/US20250248948A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6845162B2 (ja) | ケタミン経皮送達システム | |
| CN1227012C (zh) | 用于局部传送环加氧酶－2酶抑制剂的药物组合物 | |
| US20050187212A1 (en) | Pharmaceutical composition for topical delivery of meloxicam | |
| JP6259454B2 (ja) | ジクロフェナク製剤 | |
| US12201622B2 (en) | Continuous delivery of lenalidomide and other immunomodulatory agents | |
| JP7779642B2 (ja) | ロキソプロフェン配合皮膚用外用剤 | |
| JP2023523155A (ja) | 慢性疼痛治療のためのカンナビジオール及び／又はテトラヒドロカンナビノールを含有する経皮製剤及び／又は局所製剤 | |
| JP2022550569A5 (enExample) | ||
| CN101530401A (zh) | 一种用于治疗急慢性炎性疼痛的复方透皮贴片 | |
| CN1209108C (zh) | 一种经皮肤传递的止吐剂成份和含相同成份的制剂 | |
| JP2009013171A (ja) | メマンチン含有経皮吸収製剤 | |
| EP2491924B1 (en) | Water-based paste containing diclofenac sodium | |
| US8852628B1 (en) | Transdermal drug delivery system for diclofenac | |
| JP2023520845A (ja) | ヒドロキシクロロキン及び／又はクロロキンを含む経口送達システム | |
| JP2024514843A5 (enExample) | ||
| JP2016014052A (ja) | 含水貼付剤 | |
| JP2024514362A5 (enExample) | ||
| JP2023521563A (ja) | ヒドロキシクロロキン及び／又はクロロキンを含む経皮及び／又は局所送達システム | |
| JP4163859B2 (ja) | 効果の高い神経弛緩剤を含有する経皮治療システム | |
| US20170014417A1 (en) | Pharmaceutical administration system for the transdermal application of vardenafil | |
| EP1547595A1 (en) | Patch for transdermal administration | |
| JP5091472B2 (ja) | 粘着剤及び貼付剤 | |
| WO2010098230A1 (ja) | 経皮投与製剤 | |
| US20050163831A1 (en) | Patch for transdermal administration | |
| JP2024513961A5 (enExample) |